• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时检测 HIV-1 p24 抗原和 HIV-1 和 -2 抗体的两种 HIV 筛查试验的特异性。

Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2.

机构信息

Division of Clinical Microbiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland.

Blood Transfusion Centre, Swiss Red Cross, Hebelstrasse 10, 4056 Basel, Switzerland.

出版信息

J Virol Methods. 2017 Nov;249:143-146. doi: 10.1016/j.jviromet.2017.09.005. Epub 2017 Sep 8.

DOI:10.1016/j.jviromet.2017.09.005
PMID:28893550
Abstract

This study aimed at assessing the specificity of the Elecsys HIV combi PT in comparison to the ARCHITECT HIV Ag/Ab Combo. With both of these assays, 3997 unselected sera from patients of a tertiary health care centre in Basel, Switzerland, were screened for HIV. Reactive sera were reanalysed on the VIDAS HIV Duo Ultra to identify false-reactive specimens prior to confirmation by quantitative PCR and line immunoassay. The Elecsys compared to the ARCHITECT shows a similar specificity (99.7% versus 99.8%) but a slightly lower positive predictive value (71.8% versus 80%). Samples tested with a cut-off index (COI) between 0.91 and 4.85 (cut-off <0.9) with the Elecsys and with a signal to cut-off index (S/CO) between 1.09 and 12.49 (cut-off <1.0) with the ARCHITECT were false-reactive. There was no false-reactive result with the VIDAS. Of the false-reactive samples, 66.7% could be related to patient-specific underlying conditions. The HIV two-tiered diagnostic algorithm proposed in this work improved the positive predictive values of the Elecsys or ARCHITECT to 100% when the results of the VIDAS were included. Values just above the cut-off are highly suspicious to be false-reactive and high COI or S/CO ratios are associated with true positivity.

摘要

本研究旨在评估 Elecsys HIV combi PT 与 ARCHITECT HIV Ag/Ab Combo 的特异性。使用这两种检测方法,对瑞士巴塞尔一家三级保健中心的 3997 份未经选择的患者血清进行了 HIV 筛查。对反应性血清进行 VIDAS HIV Duo Ultra 重新分析,以在通过定量 PCR 和线免疫测定确认之前识别假反应性标本。与 ARCHITECT 相比,Elecsys 的特异性相似(99.7%对 99.8%),但阳性预测值略低(71.8%对 80%)。用 Elecsys 检测到的 cutoff 指数(COI)在 0.91 到 4.85 之间(cutoff <0.9)和用 ARCHITECT 检测到的信号与 cutoff 指数(S/CO)在 1.09 到 12.49 之间(cutoff <1.0)的样本为假反应性。VIDAS 无假反应性结果。假反应性样本中,66.7%可能与患者特定的基础疾病有关。当包括 VIDAS 的结果时,本研究提出的 HIV 两步诊断算法将 Elecsys 或 ARCHITECT 的阳性预测值提高到 100%。接近 cutoff 值的结果高度怀疑为假反应性,高 COI 或 S/CO 比值与真正的阳性相关。

相似文献

1
Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2.同时检测 HIV-1 p24 抗原和 HIV-1 和 -2 抗体的两种 HIV 筛查试验的特异性。
J Virol Methods. 2017 Nov;249:143-146. doi: 10.1016/j.jviromet.2017.09.005. Epub 2017 Sep 8.
2
Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay - evaluation of a new HIV assay.新型第四代HIV抗原/抗体联合电化学发光免疫分析法的性能评估——一种新型HIV检测法的评估
Int J STD AIDS. 2014 Mar;25(4):267-72. doi: 10.1177/0956462413499909. Epub 2013 Aug 5.
3
Performances of four fourth-generation human immunodeficiency virus-1 screening assays.四种第四代人类免疫缺陷病毒 1 筛查检测方法的性能评估。
J Med Virol. 2012 Dec;84(12):1884-8. doi: 10.1002/jmv.23423.
4
BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.伯乐 BioPlex® HIV Ag-Ab 检测:在低流行人群中假阳性的发生率及其对当前 HIV 检测算法的影响。
J Clin Virol. 2019 Jul;116:1-3. doi: 10.1016/j.jcv.2019.04.002. Epub 2019 Apr 6.
5
Using Elecsys® HIV Combi PT assay to identify acute and early HIV infection in a teaching hospital of southwest China.在中国西南部一家教学医院使用电化学发光免疫分析法(Elecsys® HIV Combi PT assay)来识别急性和早期HIV感染。
Int J STD AIDS. 2016 Mar;27(3):213-8. doi: 10.1177/0956462415579589. Epub 2015 Mar 29.
6
Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.三种人类免疫缺陷病毒抗原-抗体联合免疫测定法的性能评估
J Virol Methods. 2006 Apr;133(1):20-6. doi: 10.1016/j.jviromet.2005.10.013. Epub 2005 Nov 28.
7
Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.在 EVOLIS™ 自动化系统上对第四代 Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA 与 Abbott ARCHITECT HIV Ag/Ab Combo、Ortho Anti-HIV 1+2 EIA 在 Vitros ECi 上和西门子 HIV-1/O/2 增强型在 Advia Centaur 上的性能比较。
J Clin Virol. 2013 Dec;58 Suppl 1:e79-84. doi: 10.1016/j.jcv.2013.08.009.
8
Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.新型第四代HIV筛查检测法Elecsys HIV combi的多中心评估
Clin Lab. 2006;52(9-10):463-73.
9
Performance evaluation of the ADVIA Centaur(®) HIV Ag/Ab Combo assay.ADVIA Centaur(®) HIV Ag/Ab Combo assay 的性能评估。
J Virol Methods. 2010 Dec;170(1-2):16-20. doi: 10.1016/j.jviromet.2010.08.012. Epub 2010 Aug 17.
10
Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra.新型抗原与抗体联合检测的人类免疫缺陷病毒筛查检测方法VIDAS HIV DUO Ultra的评估
J Clin Microbiol. 2002 Apr;40(4):1420-6. doi: 10.1128/JCM.40.4.1420-1426.2002.

引用本文的文献

1
HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests.使用第四代试剂的HIV检测算法降低了筛查试验的假阳性率。
Sci Rep. 2025 Apr 10;15(1):12310. doi: 10.1038/s41598-025-97169-y.
2
HIV false positive screening serology due to sample contamination reduced by a dedicated sample and platform in a high prevalence environment.在高流行环境中,通过专用样本和平台可降低因样本污染导致的 HIV 假阳性筛查血清学。
PLoS One. 2021 Jan 11;16(1):e0245189. doi: 10.1371/journal.pone.0245189. eCollection 2021.
3
The evaluation of low cut-off index values of Elecsys HIV combi PT assay in predicting false-positive results.
Elecsys HIV combi PT 检测低值截断指数评估对预测假阳性结果的影响。
J Clin Lab Anal. 2020 Nov;34(11):e23503. doi: 10.1002/jcla.23503. Epub 2020 Aug 25.
4
Risks of requiring a dedicated molecular specimen for HIV diagnosis and a potential strategy for mitigation.需要专用分子标本进行 HIV 诊断的风险及潜在缓解策略。
PLoS One. 2020 Aug 13;15(8):e0237580. doi: 10.1371/journal.pone.0237580. eCollection 2020.
5
Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection.急性 HIV 感染个体开始抗逆转录病毒治疗时血清反应性降低。
J Clin Microbiol. 2019 Sep 24;57(10). doi: 10.1128/JCM.00757-19. Print 2019 Oct.